Capmatinib Cost 2026: Updated Prices with Insurance vs. Without

Capmatinib (Tabrecta) is a highly selective MET receptor tyrosine kinase inhibitor that specifically inhibits MET receptors and the phosphorylation process of MET-mediated downstream signaling proteins, thereby suppressing the proliferation and migration of c-MET-dependent tumor cells and inducing their apoptosis. Clinically, it is used for the treatment of adult patients with metastatic non-small cell lung cancer. This drug has the ability to penetrate the blood-brain barrier and demonstrates certain inhibitory effects on brain tumor lesions.

Price of Capmatinib (Tabrecta)

Currently, multiple versions of Capmatinib (Tabrecta) are available on the market, with pricing varying across versions:

Lao Lucius Version

The generic version of Capmatinib produced by Lao Lucius Pharmaceuticals is available in a specification of 200mg × 60 tablets per box. Based on current market information, its price is approximately between $2,650 and $3,100 per box.

Swiss Novartis Version

The original Novartis version offers two specifications: 200mg60 capsules and 150mg60 capsules, with prices ranging from approximately $4,282 to $62,100.

The above prices are for reference only. The actual selling price of Capmatinib may fluctuate due to multiple factors such as exchange rate changes, sales region, drug version, and purchasing channels. Given the uncertainty in pricing, it is recommended to verify the latest quotes before purchasing. Additionally, it is essential to ensure that the medication is obtained through legitimate channels.

How to Purchase Capmatinib (Tabrecta)

The main purchasing channels for Lucius Pharmaceuticals Capmatinib (Tabrecta) are as follows:

Hospital Pharmacies

In regions where the drug has been approved for marketing, patients can purchase it directly from hospital pharmacies with a doctor's prescription.

Online Pharmacies

Legitimate and licensed online pharmacies may offer this drug. It is necessary to confirm that the website holds a valid license for pharmaceutical sales and to carefully verify the source of the medication.

Retail Pharmacy Chains

Some large retail pharmacy chains may stock the drug. Patients can inquire at nearby pharmacies for specific availability.

Medical Institutions

Patients can consult domestic medical institutions to inquire whether they can assist in purchasing the required version of Capmatinib and obtain the latest pricing information.

Side Effects of Capmatinib (Tabrecta)

Common side effects observed in the clinical use of Capmatinib include:

Edema

As a frequent side effect, it often manifests as swelling in the hands, feet, and face.

Nausea

A typical gastrointestinal reaction, often accompanied by loss of appetite, which may affect nutritional intake and quality of life.

Vomiting

If severe and left untreated, vomiting may lead to dehydration and other complications.

Fatigue

Patients may experience persistent tiredness and weakness, which can impact daily activities.

During the medication period, patients must strictly follow the doctor's guidance. If side effects occur, they should promptly inform their doctor to ensure timely and appropriate management.